Results 251 to 260 of about 1,411,652 (360)

Epidemiology for Infectious Hepatitis

, 1954
Kiyowo Kosaka, Keitaro Seto, Toshio Yuasa, Shigemi Ogino, Kazuhiko Inui, Masao Iwahara, Masuo Hino, Naoki Yamamoto, Tatsuo Ishida   +8 more
openalex   +2 more sources

Adverse drug reactions, particularly liver disorders, drive interruptions in anti‐tuberculosis treatment: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a key driver of missed doses of anti‐tuberculosis (TB) therapy. We aimed to determine the relative burden of ADR‐driven missed doses, the missed dose patterns associated with ADRs, and the association between specific ADRs and missed doses.
Eleanor G. Dixon, Evita Biraua, Edvards Brencsēns, Vitālijs Pašuks, Vija Riekstina, Anete Šperberga, Marisa D. Muckian, James W. Dear, Liga Kuksa, Derek J. Sloan, Helen R. Stagg   +10 more
wiley   +1 more source

Capturing virus evolution by proteomic bioinformatics: Hunting for characteristic mutations in the hepatitis E virus genome

Virulence, 2018
Dominik Harms, Bo Wang, C. Patrick Papp, C.-Thomas Bock   +3 more
doaj   +1 more source

Risk of tuberculosis and hepatitis B reactivation during adalimumab use in the treatment of hidradenitis suppurativa. [PDF]

Sci Rep
Karakoyun Ö, Ayhan E.
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Feasibility of eliminating adult hepatitis B in Guangdong by 2030: A modeling study. [PDF]

Infect Dis Model
Sun N, Shao X, Hou C, Wei X, Lin W, Yang Y, Chen L, Hon C, Zhu G, Sun J, Sun L.   +10 more
europepmc   +1 more source

Chronic Infectious Hepatitis (The anicteric form and its change to cirrhosis of the liver)

, 1959
Tosaku Maeda
openalex   +2 more sources

Psychoactive prescription drug use and misuse in patients on opioid agonist treatment

British Journal of Clinical Pharmacology, EarlyView.
Aims To identify the patterns and trends in prescription drug use and misuse in patients on opioid agonist treatment. Methods We used data from the OPPIDUM programme, which collects data from patients attending substance abuse treatment facilities. Data collected include use of psychoactive prescription drugs in the past week.
Thomas Soeiro, Clémence Lacroix, Élisabeth Jouve, Élisabeth Frauger, Maryse Lapeyre‐Mestre, Joëlle Micallef   +5 more
wiley   +1 more source

Critical analysis of the liver cancer policies and programs in China: implications for international liver cancer control. [PDF]

Glob Health Res Policy
Chen X, Shi J, Xue Y, Lai Y, Song M, Ung COL, Hu H.   +6 more
europepmc   +1 more source

CLTNICAL OBSERVATION ON THE PATIENTS WITH SERUM HEPATITIS

, 1959
G Wakisaka, Teruo Fujita, Fumihiro Ichida, Toshio Yamamoto, Tadashi Sakuno, Shigeru Morita, S. Hashimoto, Y Nakamura, Shigeyoshi Tomita, Chizuko Ishida, Hideto Higashi   +10 more
openalex   +2 more sources